16:43 EDT Vaccinex files to sell 490,509 shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCNX:
- Vaccinex Completes Key Study Phase for Alzheimer’s Drug
- Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
- Vaccinex reports completion of last patient visit in SIGNAL-AD Phase 1b/2 study
- Biotech Alert: Searches spiking for these stocks today
- option delistings on June 3rd